Intra-Cellular Therapies Income Statement

Financials in millions USD. Fiscal year is March - February.

Millions USD. Fiscal year is Mar - Feb.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	May '25 May 4, 2025	Feb '25 Feb 2, 2025	Jan '24 Jan 28, 2024	Jan '23 Jan 29, 2023	Jan '22 Jan 30, 2022	Jan '21 Jan 31, 2021	2017 - 2021
Revenue	162,952	159,514	152,669	157,403	151,157	132,110	Upgrade
Revenue Growth (YoY)	7.32%	4.48%	-3.01%	4.13%	14.42%	19.86%	Upgrade
Cost of Revenue	108,618	106,206	101,709	104,625	100,325	87,257	Upgrade
Gross Profit	54,334	53,308	50,960	52,778	50,832	44,853	Upgrade
Selling, General & Admin	29,611	28,748	26,598	26,284	25,406	24,447	Upgrade
Operating Expenses	32,754	31,782	29,271	28,739	27,792	26,575	Upgrade
Operating Income	21,580	21,526	21,689	24,039	23,040	18,278	Upgrade
Interest Expense	-2,451	-2,321	-1,943	-1,617	-1,347	-1,347	Upgrade
Interest & Investment Income	168	201	178	55	44	47	Upgrade
EBT Excluding Unusual Items	19,297	19,406	19,924	22,477	21,737	16,978	Upgrade
Pretax Income	19,297	19,406	19,924	22,477	21,737	16,978	Upgrade
Income Tax Expense	4,658	4,600	4,781	5,372	5,304	4,112	Upgrade
Net Income	14,639	14,806	15,143	17,105	16,433	12,866	Upgrade
Net Income to Common	14,639	14,806	15,143	17,105	16,433	12,866	Upgrade
Net Income Growth	-1.55%	-2.23%	-11.47%	4.09%	27.72%	14.45%	Upgrade
Shares Outstanding (Basic)	991	990	999	1,022	1,054	1,074	Upgrade
Shares Outstanding (Diluted)	994	993	1,002	1,025	1,058	1,078	Upgrade
Shares Change (YoY)	-0.33%	-0.90%	-2.24%	-3.12%	-1.85%	-1.73%	Upgrade
EPS (Basic)	14.78	14.96	15.16	16.74	15.59	11.98	Upgrade
EPS (Diluted)	14.73	14.91	15.11	16.69	15.53	11.94	Upgrade
EPS Growth	-1.27%	-1.32%	-9.47%	7.47%	30.07%	16.49%	Upgrade
Free Cash Flow	15,194	16,325	17,946	11,496	14,005	16,376	Upgrade
Free Cash Flow Per Share	15.29	16.44	17.91	11.22	13.24	15.19	Upgrade
Dividend Per Share	6.800	9.050	8.520	7.790	6.850	6.150	Upgrade
Dividend Growth	-21.66%	6.22%	9.37%	13.72%	11.38%	10.21%	Upgrade
Gross Margin	33.34%	33.42%	33.38%	33.53%	33.63%	33.95%	Upgrade
Operating Margin	13.24%	13.49%	14.21%	15.27%	15.24%	13.84%	Upgrade
Profit Margin	8.98%	9.28%	9.92%	10.87%	10.87%	9.74%	Upgrade
Free Cash Flow Margin	9.32%	10.23%	11.76%	7.30%	9.26%	12.40%	Upgrade
EBITDA	25,498	25,287	24,936	27,014	25,902	20,797	Upgrade
EBITDA Margin	15.65%	15.85%	16.33%	17.16%	17.14%	15.74%	Upgrade
D&A For EBITDA	3,918	3,761	3,247	2,975	2,862	2,519	Upgrade
EBIT	21,580	21,526	21,689	24,039	23,040	18,278	Upgrade
EBIT Margin	13.24%	13.49%	14.21%	15.27%	15.24%	13.84%	Upgrade
Effective Tax Rate	24.14%	23.70%	24.00%	23.90%	24.40%	24.22%	Upgrade
Advertising Expenses	-	1,200	1,100	1,100	1,000	909	Upgrade

Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.